Industry group PhRMA continues to fight a Trump-era final rule to allow drug imports from Canada as the lobbying group has now petitioned the FDA to reject New Mexico’s import plan because of missing details that may make the imported drugs unsafe and not cost-effective.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,